Column Group
Latest statistics and disclosures from Column Group's latest quarterly 13F-HR filing:
Tip: Access up to 7 years of quarterly data
Positions held by Column Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Column Group
Column Group holds 6 positions in its portfolio as reported in the September 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Oric Pharmaceuticals (ORIC) | 52.2 | $36M | 3.5M | 10.25 |
|
|
Tenaya Therapeutics (TNYA) | 26.1 | $18M | 9.4M | 1.93 |
|
|
Surrozen | 13.9 | $9.7M | 810k | 11.98 |
|
|
Rapt Therapeutics (RAPT) | 7.7 | $5.4M | 2.7M | 2.01 |
|
|
Sagimet Biosciences Inc-a (SGMT) | 0.1 | $48k | 17k | 2.77 |
|
|
Revolution Medicines (RVMD) | 0.0 | $2.1k | 46.00 | 45.35 |
|
Past Filings by Column Group
SEC 13F filings are viewable for Column Group going back to 2020
- Column Group 2024 Q3 filed Nov. 14, 2024
- Column Group 2024 Q2 filed Aug. 15, 2024
- Column Group 2024 Q1 filed May 15, 2024
- Column Group 2023 Q4 filed Feb. 9, 2024
- Column Group 2023 Q3 filed Nov. 13, 2023
- Column Group 2023 Q2 filed July 24, 2023
- Column Group 2023 Q1 filed May 15, 2023
- Column Group 2022 Q4 filed Feb. 13, 2023
- Column Group 2022 Q3 filed Nov. 14, 2022
- Column Group 2022 Q2 filed Aug. 12, 2022
- Column Group 2022 Q1 filed May 16, 2022
- Column Group 2021 Q4 filed Feb. 11, 2022
- Column Group 2021 Q3 filed Nov. 12, 2021
- Column Group 2021 Q2 filed Aug. 16, 2021
- Column Group 2021 Q1 filed May 17, 2021
- Column Group 2020 Q4 filed Feb. 16, 2021